Organon & Co.

Last updated September 27, 2026

Favorite this organization

Organization details

Legal name: Organon & Co.
Ownership: Public
Status: Active
Sector (GICS): Health Care
SIC code: 2834 — Pharmaceutical Preparations
Headquarters city: Jersey City
Headquarters state / province: New Jersey
Headquarters country: United States
Fiscal year end: December
Ticker symbol: OGN
Primary stock exchange: NYSE

Identifiers

SEC CIK: 0001821825
EIN: 46-4838035
Wikidata ID: Q903372

Board of directors

Follow this board

Alan Ezekowitz · Director
Since 2023
Carrie Smith Cox · Director · Executive Chair
Since 2023
Cynthia M. Patton · Director
Since 2023
Deborah R. Leone · Director
Since 2023
Grace Puma Whiteford · Director
Since 2023
Helene D. Gayle · Director
Since 2023
Kevin Ali · Director · Chief Executive Officer
Since 2023
Ma. Fatima Francisco · Director
Since 2023
Martha E. McGarry · Director
Since 2023
Philip Ozuah · Director
Since 2023
Ramona Sequeira · Director
Since 2025
Robert Essner · Director
Since 2023
Rochelle B. Lazarus · Director
Since 2023
Shalini Sharp · Director Overboarded
Since 2023

Chief executives

Kevin Ali · Chief Executive Officer

Dates unknown

Director election results

Annual meeting of June 9, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Board connections

10 of this board's directors also sit on 18 other boards. 9 are in the same sector.

Shared director Other board Same sector +2 more in the list below

Septerna Inc. Same sector
via Alan Ezekowitz and Shalini Sharp
BeOne Medicines Ltd. Same sector
via Shalini Sharp
Blackstone Inc.
via Rochelle B. Lazarus
Cartesian Therapeutics Inc. Same sector
via Carrie Smith Cox
Corebridge Financial Inc.
via Deborah R. Leone
Edwards Lifesciences Corporation Same sector
via Ramona Sequeira
Eikon Therapeutics Inc. Same sector
via Ma. Fatima Francisco
Fulcrum Therapeutics Inc. Same sector
via Alan Ezekowitz
HP Inc.
via Ma. Fatima Francisco
Iambic Therapeutics Inc. Same sector
via Shalini Sharp
Neurocrine Biosciences Inc. Same sector
via Shalini Sharp
Palo Alto Networks Inc.
via Helene D. Gayle
Phillips 66
via Grace Puma Whiteford
Solventum Corporation Same sector
via Carrie Smith Cox
Target Corporation
via Grace Puma Whiteford
Texas Instruments Incorporated
via Carrie Smith Cox
The Cigna Group
via Philip Ozuah
The Coca-Cola Company
via Helene D. Gayle

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months: $854,704; 2 purchases by 2 insiders
Sold, last 12 months: $200,307; 1 sale by 1 insider

Date	Insider	Transaction	Shares	Price	Value
Nov 7, 2026	Arjona Ferreira Juan Camilo Officer (Head of R&D & CMO)	Option exercise	+6,447	—	—
Nov 7, 2026	Drinane Juliana Papa Officer (Head of Mfg & Supply)	Option exercise	+3,626	—	—
Nov 7, 2026	Arjona Ferreira Juan Camilo Officer (Head of R&D & CMO)	Shares withheld for tax	−2,314	$13.87	$32,095
Nov 7, 2026	Drinane Juliana Papa Officer (Head of Mfg & Supply)	Shares withheld for tax	−1,242	$13.87	$17,227
Nov 7, 2026	Holzbaur Lynette Officer (SVP and Corporate Controller)	Option exercise	+2,418	—	—
Nov 7, 2026	Holzbaur Lynette Officer (SVP and Corporate Controller)	Shares withheld for tax	−689	$13.87	$9,556
Nov 5, 2026	Holzbaur Lynette Officer (SVP and Corporate Controller)	Option exercise	+3,038	—	—
Nov 5, 2026	Holzbaur Lynette Officer (SVP and Corporate Controller)	Shares withheld for tax	−866	$13.83	$11,977
Aug 11, 2026	Arjona Ferreira Juan Camilo Officer (Head of R&D & CMO)	Option exercise	+11,519	—	—
Aug 11, 2026	Arjona Ferreira Juan Camilo Officer (Head of R&D & CMO)	Shares withheld for tax	−4,134	$13.62	$56,305
Aug 5, 2026	Drinane Juliana Papa Officer (Head of Mfg & Supply)	Open-market sale	−14,761	$13.57	$200,307
May 6, 2026	Holzbaur Lynette Officer (SVP and Corporate Controller)	Open-market purchase	+26,448	$13.35	$353,086
Mar 31, 2026	Drinane Juliana Papa Officer (Interim Head of Mfg & Supply)	Option exercise	+6,378	—	—
Mar 31, 2026	Arjona Ferreira Juan Camilo Officer (Head of R&D & CMO)	Option exercise	+13,431	—	—
Mar 31, 2026	Karp Daniel Officer (Executive VP, Corp. Dev.)	Option exercise	+11,338	—	—

Peers

Compare boards

Organizations in the same sector, closest in location and size first.

3M Company NYSE: MMM · ST Paul, United States Organization ABVC BioPharma Inc. Nasdaq: ABVC · Fremont, United States Organization ACADIA Pharmaceuticals Inc. Nasdaq: ACAD · SAN Diego, United States Organization ADMA Biologics Inc Nasdaq: ADMA · Ramsey, United States Organization

Questions about Organon & Co.

Who is the CEO of Organon & Co.?

Kevin Ali is Organon & Co.'s Chief Executive Officer.

How many directors are on Organon & Co.'s board?

Organon & Co.'s board has 14 directors: Alan Ezekowitz, Carrie Smith Cox, Cynthia M. Patton, Deborah R. Leone, Grace Puma Whiteford, Helene D. Gayle, Kevin Ali, Ma. Fatima Francisco, Martha E. McGarry, Philip Ozuah and 4 others.

Are Organon & Co. insiders buying or selling shares?

Over the last 12 months, Organon & Co. insiders bought $854,704 of shares in 2 purchases and sold $200,307 of shares in 1 sale on the open market, as reported to the SEC on Forms 4 and 5.

How is Organon & Co. connected to…? → Spot something wrong? Report a correction

Embed this board on your site

Paste this where the board should appear. It always shows the current directors and links back here.

<div data-bod-board="organon-co"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>

Reviews (0)

No reviews yet. Be the first to write one.